Strategic partnerships Viedoc is actively expanding its ecosystem through partner programs and collaborations with CROs and CTMS providers. Notable recent moves include Trialt partnership (Apr 2026), SimpleTrials joining the Verified Partner Program (Aug 2025), and PHARMASEAL integration (Jul 2025). Target opportunities: approach CROs, CTMS platforms, and EDC integrators to co-sell or embed Viedoc capabilities.

Integrated patient journey Recent product releases emphasize end-to-end digital patient engagement, including recruitment, eConsent, ePRO, continuous communication, and digital compensation, all aligned with ICH E6(R3). This breadth creates upsell opportunities with sponsors seeking unified, compliant trial workflows and advanced patient-centric features.

Medical coding enhancements Viedoc enhanced its eClinical suite with WHODrug Koda integration for automated medical coding, signaling a push toward smarter data automation and quality. Potential to upsell to customers needing higher coding accuracy, faster study timelines, and regulatory-ready datasets.

Global scale and trust Trusted in 75+ countries and powering thousands of studies with millions of participants demonstrates global reach and reliability. This positions Viedoc as a viable solution for multinational trials and sponsors seeking scalable, compliant trial management across diverse geographies.

Hybrid ecosystem growth Active tech stack and marketing integrations (AWS, Azure DevOps, HubSpot, Prometheus, Piwik PRO) indicate a modern, cloud-first, data-driven approach. Sales opportunities exist with mid-market biotech and pharma firms aiming to modernize IT infrastructure, analytics, and partner ecosystems.